Medexus Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, and pediatrics. Medexus Pharmaceuticals serves customers North America and Canada.
This week, all eyes were on the SpaceX (SPCX) IPO, which priced at $135 per share — an implied $1.77 trillion valuation and the largest debut in...